Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
Sponsor: LifeNet Health
Summary
Prospective registry and retrospective data collection study to assess the efficacy and safety of Vivigen Cellular Bone Matrix (Vivigen) in orthopaedic trauma patients who require bone grafting in the acute, delayed, non-union fracture as well as use in fusion procedure settings.
Official title: Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care: A Multi-Center Prospective Registry and Retrospective Data Collection Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2021-06-01
Completion Date
2026-07-31
Last Updated
2025-04-02
Healthy Volunteers
No
Conditions
Interventions
Vivigen Cellular Bone Matrix
Allograft bone matrix
Locations (4)
OrlandoHealth
Orlando, Florida, United States
RWJBarnabas Health
Jersey City, New Jersey, United States
Duke University Medical Center
Durham, North Carolina, United States
Sentara Hospitals
Norfolk, Virginia, United States